Gufic BioSciences Current Share Price | Gufic BioSciences Stock Screener
GUFICBIO
Pharmaceuticals
Gufic BioSciences Current Stock Price Today
Live Share Price NSE
₹421.75
▲
0.35 (0.08%)
Live Share Price BSE
₹422.45
▲
1.80 (0.43%)
As of August 19, 2026, the live Gufic BioSciences share price (NSE: GUFICBIO) is ₹421.75 on NSE and ₹422.45 on BSE, up 0.08% from the previous close, with shares trading between ₹416.65 and ₹426.00 in today's trading session, and a 52-week range of ₹273.50–₹433.00.
Analyse GUFICBIO stock price history and track historical price performance.
Use the Gufic BioSciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Gufic BioSciences Market Cap
₹4,233.93 Cr.
GUFICBIO P/E Ratio (TTM)
67.35
Gufic BioSciences P/B Ratio
6.50
EPS (TTM)
₹6.40
Dividend Yield
0.02%
Debt to Equity
0.59
GUFICBIO 52 Week High
₹433.00
Gufic BioSciences 52 Week Low
₹273.50
Operating Margin
18.00%
Profit Margin
8.43%
GUFICBIO Revenue (TTM)
₹261.00
EBITDA
₹47.00
Net Income
₹22.00
Total Assets
₹1,342.00
Total Equity
₹665.00
Gufic BioSciences Current Share Price Chart
Track the current Gufic BioSciences share price and stock price with an interactive chart. Analyse GUFICBIO price trends, trading volume, historical performance, and volatility across different timeframes — the complete Gufic BioSciences stock quote in one place.
Gufic BioSciences Company Profile - Fundamental Screener
Screen Gufic BioSciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for GUFICBIO shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE742B01025
Gufic BioSciences Balance Sheet Screener
Screen GUFICBIO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 |
|---|---|---|---|
| Assets | |||
| Total Assets | 1,342 | 1,169 | 1,093 |
| Current Assets | 802 | 625 | 601 |
| Fixed Assets | 513 | 506 | 159 |
| Liabilities | |||
| Total Liabilities | 0 | 0 | 0 |
| Current Liabilities | 160 | 181 | 188 |
| Non-Current Liabilities | 0 | 0 | 0 |
| Shareholders' Equity | |||
| Total Equity | 665 | 601 | 533 |
| Share Capital | 10 | 10 | 10 |
| Reserves & Surplus | 655 | 591 | 523 |
Gufic BioSciences Income Statement Screener - Profit & Revenue Analysis
Screen Gufic BioSciences income statement and profit fundamentals.
Analyze GUFICBIO quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Gufic BioSciences share price evaluation.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 261 | 251 | 232 | 239 | 225 | 205 | 210 | 204 | 204 | 196 | 202 | 215 | 196 |
| Expenses | 214 | 205 | 198 | 199 | 190 | 179 | 174 | 166 | 167 | 161 | 165 | 176 | 159 |
| EBITDA | 47 | 46 | 34 | 40 | 34 | 27 | 36 | 39 | 37 | 35 | 37 | 40 | 36 |
| Operating Profit % | 18.00% | 19.00% | 14.00% | 16.00% | 15.00% | 13.00% | 16.00% | 19.00% | 18.00% | 18.00% | 18.00% | 18.00% | 18.00% |
| Depreciation | 8 | 8 | 8 | 8 | 8 | 8 | 5 | 4 | 4 | 4 | 4 | 4 | 4 |
| Interest | 9 | 9 | 8 | 10 | 9 | 8 | 5 | 5 | 5 | 4 | 3 | 5 | 4 |
| Profit Before Tax | 30 | 29 | 18 | 23 | 17 | 11 | 26 | 29 | 28 | 27 | 30 | 31 | 28 |
| Tax | 8 | 7 | 5 | 6 | 4 | 3 | 7 | 8 | 7 | 7 | 7 | 8 | 7 |
| Net Profit | 22 | 22 | 12 | 17 | 13 | 8 | 19 | 22 | 21 | 20 | 22 | 23 | 21 |
| EPS | 2.22 | 2.18 | 1.24 | 1.68 | 1.30 | 0.77 | 1.93 | 2.17 | 2.08 | 2.00 | 2.23 | 2.39 | 2.13 |
Gufic BioSciences Cash Flow Screener - Liquidity Fundamentals
Screen GUFICBIO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March |
|---|---|---|
| Operating Activities | 123 | -8 |
| Investing Activities | -71 | -102 |
| Financing Activities | -37 | 82 |
| Net Cash Flow | 15 | -28 |
Gufic BioSciences Shareholding Pattern Screener
See Gufic BioSciences shareholding pattern with promoter, FII, and DII holdings.
Check Gufic BioSciences promoter holding and ownership changes for GUFICBIO on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 72.50% | 72.50% | 72.51% | 72.51% | 72.50% | 72.50% | 72.51% | 72.51% |
| FII Holding | 0.42% | 0.46% | 0.31% | 0.32% | 0.34% | 0.44% | 0.12% | 0.23% |
| DII Holding | 3.83% | 3.68% | 3.39% | 3.38% | 3.65% | 3.74% | 2.20% | 2.39% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 13.93% | 14.00% | 15.15% | 15.10% | 14.45% | 14.13% | 16.72% | 16.36% |
| Other Holding | 9.31% | 9.36% | 8.64% | 8.70% | 9.06% | 9.19% | 8.45% | 8.52% |
| Shareholder Count | 29,223 | 29,753 | 31,844 | 31,876 | 31,420 | 30,362 | 34,695 | 32,250 |
Gufic BioSciences Share Dividend Screener - Share Yield Analysis
Check Gufic BioSciences dividend history with payout and yield data.
View Gufic BioSciences dividend details including ex-dates and amounts for GUFICBIO stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.10 | 0.02% |
| 2025-March | ₹0.10 | 0.04% |
| 2024-March | ₹0.10 | 0.03% |
| 2023-March | ₹0.10 | 0.04% |
| 2022-March | ₹0.10 | 0.05% |
| 2021-March | ₹0.10 | 0.04% |
| 2020-March | ₹0.05 | 0.04% |
| 2019-March | ₹0.05 | 0.10% |
| 2018-March | ₹0.05 | 0.07% |
| 2017-March | ₹0.05 | 0.05% |
Gufic BioSciences Stock Index Membership
See which indices include Gufic BioSciences stock.
Check GUFICBIO index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
Gufic BioSciences Market Events Screener - Corporate Actions
Get Gufic BioSciences corporate actions including splits, bonuses, and buybacks.
Check Gufic BioSciences stock events that may affect GUFICBIO share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-04 | 2026-09-04 | Annual General Meeting | NA | 4.33% |
| 2026-08-28 | 2026-08-28 | Dividend | ₹ 0.10 /share | 29.24% |
| 2026-08-14 | 2026-08-14 | Quarterly Result Announcement | NA | 2.10% |
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | 12.89% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 1.49% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -0.69% |
| 2025-09-29 | 2025-09-29 | Annual General Meeting | NA | -3.20% |
| 2025-09-22 | 2025-09-22 | Dividend | ₹ 0.10 /share | -5.49% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -2.72% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 2.75% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -4.73% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -7.61% |
| 2024-09-25 | 2024-09-25 | Annual General Meeting | NA | -0.95% |
| 2024-09-17 | 2024-09-19 | Dividend | ₹ 0.10 /share | 27.37% |
| 2023-09-29 | 2023-09-29 | Annual General Meeting | NA | -7.11% |
Gufic BioSciences Competitors Screener - Peer Comparison
Screen GUFICBIO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 463,072 | 38.47 | 61,674 | 12.69% | 11,565 | 47.09 |
| Divis Laboratories | 225,038 | 77.15 | 11,067 | 13.95% | 2,568 | 71.85 |
| Torrent Pharmaceuticals | 183,832 | 86.03 | 13,886 | 20.34% | 2,138 | 45.42 |
| Cipla | 117,138 | 35.17 | 29,045 | 2.24% | 3,870 | 50.74 |
| Zydus Life Science | 114,228 | 25.48 | 27,658 | 17.64% | 5,026 | 50.68 |
| Lupin | 102,191 | 18.62 | 29,039 | 26.75% | 5,356 | 30.04 |
| Dr Reddys Laboratories | 100,160 | 31.62 | 35,059 | 3.90% | 4,158 | 49.18 |
| Mankind Pharma | 100,160 | 48.30 | 14,636 | 14.85% | 1,938 | 43.34 |
| Laurus Labs | 96,489 | 91.23 | 6,868 | 22.01% | 890 | 61.64 |
| Aurobindo Pharma | 93,332 | 25.93 | 34,145 | 5.56% | 3,503 | 55.68 |
Gufic BioSciences Company Announcements - News Screener
Screen GUFICBIO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-08-19 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-19 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-19 | Announcement under Regulation 30 (LODR)-Acquisition | - |
| 2026-08-19 | Results - Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30 2026 | - |
| 2026-08-19 | Board Meeting Outcome for Meeting Held On Friday August 14 2026 | - |
| 2026-08-17 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-17 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-08-17 | Reg. 34 (1) Annual Report. | - |
| 2026-08-17 | Intimation Of Record Date For Final Dividend And 42Nd Annual General Meeting | - |
| 2026-08-17 | Shareholders Meeting - 42Nd Annual General Meeting Of The Company Scheduled To Be Held On Friday September 04 2026 | - |
| 2026-08-15 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-15 | Board Meeting Intimation for Consideration And Approval Of Inter Alia Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30 2026 | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-31 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-07-31 | Board Meeting Outcome for Meeting Held On Friday July 31 2026 | - |
| 2026-07-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-07-08 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-06-26 | Closure of Trading Window | - |
| 2026-06-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-06-05 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |